Zobrazeno 1 - 1
of 1
pro vyhledávání: '"van Roy AAMGP"'
Autor:
Zeverijn LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands., van Waalwijk van Doorn-Khosrovani SB; CZ Health Insurance, Tilburg, Netherlands., van Roy AAMGP; CZ Health Insurance, Tilburg, Netherlands., Timmers L; National Health Care Institute (Zorginstituut Nederland), Diemen, Netherlands., Ly Tran TH; National Health Care Institute (Zorginstituut Nederland), Diemen, Netherlands., de Boer JE; National Health Care Institute (Zorginstituut Nederland), Diemen, Netherlands., de Wit GF; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands., Geurts BS; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Blijlevens N; Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Wymenga ANM; Department of Medical Oncology, Medical Spectrum Twente, Enschede, Netherlands., Eskens FALM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, Netherlands., Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; Oncode Institute, Utrecht, Netherlands. Electronic address: e.voest@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Feb; Vol. 23 (2), pp. 198-201.